The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Eleven Biotherapeutics, Inc. | COM | 286221106 | 5,740 | 1,907,008 | SH | SOLE | 1,907,008 | 0 | 0 | ||
Renewable Energy Group, Inc. | COM | 75972A301 | 312 | 33,570 | SH | SOLE | 33,570 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | COM | 00847X104 | 125,320 | 1,930,369 | SH | SOLE | 1,930,369 | 0 | 0 | ||
Seres Therapeutics Inc | COM | 81750R102 | 21,029 | 599,297 | SH | SOLE | 599,297 | 0 | 0 |